PE116099A1 - 5- (2-ETIL-2-H-TETRAZOLE-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE - Google Patents
5- (2-ETIL-2-H-TETRAZOLE-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINEInfo
- Publication number
- PE116099A1 PE116099A1 PE1998000563A PE00056398A PE116099A1 PE 116099 A1 PE116099 A1 PE 116099A1 PE 1998000563 A PE1998000563 A PE 1998000563A PE 00056398 A PE00056398 A PE 00056398A PE 116099 A1 PE116099 A1 PE 116099A1
- Authority
- PE
- Peru
- Prior art keywords
- tetrazole
- methyl
- piridyl
- tetrahydro
- disorder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
SE REFIERE A LA SAL DE ADICION DEL ACIDO MALEICO DE 2-ETIL-5-(1-METIL-1,2,5,6-TETRAHIDRO-3-PIRIDIL)-2H-TETRAZOL, EL ACIDO PUEDE SER MONO MALEICO. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION, QUE COMPRENDE TRATAR UNA SOLUCION DE 2-ETIL-5-(1-METIL-1,2,5,6-TETRAHIDRO-3-PIRIDIL)-2H-TETRAZOL CON ACIDO MALEICO, EN UN SOLVENTE INERTE TAL COMO TETRAHIDROFURANO (THF), SEGUIDAMENTE LA PRECIPITACION, SEPARACION, CRISTALIZACION O MICRONIZACION. LA SAL DE ADICION DEL ACIDO MALEICO DEL COMPUESTO PUEDE SER UTIL PARA EL TRATAMIENTO DE UN TRASTORNO O ENFERMEDAD CAUSADA POR EL MAL FUNCIONAMIENTO DEL SISTEMA COLINERGICO O SISTEMA MUSCARINICO COMO EL MAL DE ALZHEIMER, LESIONES TRAUMATICAS DEL CEREBRO O DESORDENES PSICOTICOSREFERING TO THE ADDITION SALT OF 2-ETHYL-5- (1-METHYL-1,2,5,6-TETRAHYDRO-3-PIRIDYL) -2H-TETRAZOLE, THE ACID MAY BE MONE MALEIC. IT ALSO REFERS TO A PROCEDURE FOR THE PREPARATION, WHICH INCLUDES TREATING A SOLUTION OF 2-ETHYL-5- (1-METHYL-1,2,5,6-TETRAHYDRO-3-PIRIDYL) -2H-TETRAZOLE WITH MALEIC ACID, IN AN INERT SOLVENT SUCH AS TETRAHYDROFURAN (THF), FOLLOWING PRECIPITATION, SEPARATION, CRYSTALLIZATION OR MICRONIZATION. THE MALEIC ACID ADDITION SALT OF THE COMPOUND MAY BE USEFUL FOR THE TREATMENT OF A DISORDER OR ILLNESS CAUSED BY THE MALFUNCTIONING OF THE CHOLINERGIC SYSTEM OR MUSCARINIC SYSTEM AS ALZHEIMER EVIL, TRAUMATIC INJURY OF THE BRAIN OR DISORDER
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE116099A1 true PE116099A1 (en) | 1999-11-23 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000563A PE116099A1 (en) | 1997-07-01 | 1998-06-25 | 5- (2-ETIL-2-H-TETRAZOLE-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (en) |
| JP (1) | JP2002507215A (en) |
| KR (1) | KR20010014297A (en) |
| CN (1) | CN1261361A (en) |
| AR (1) | AR013096A1 (en) |
| AU (1) | AU735751B2 (en) |
| BG (1) | BG103933A (en) |
| BR (1) | BR9810331A (en) |
| CA (1) | CA2293324A1 (en) |
| CO (1) | CO4940483A1 (en) |
| EA (1) | EA200000081A1 (en) |
| HU (1) | HUP0002876A2 (en) |
| IL (1) | IL133093A0 (en) |
| IS (1) | IS5278A (en) |
| JO (1) | JO2031B1 (en) |
| MA (1) | MA25138A1 (en) |
| NO (1) | NO996580L (en) |
| PE (1) | PE116099A1 (en) |
| PL (1) | PL337184A1 (en) |
| SK (1) | SK187399A3 (en) |
| TN (1) | TNSN98120A1 (en) |
| TR (1) | TR199903283T2 (en) |
| UY (2) | UY25069A1 (en) |
| WO (1) | WO1999001448A1 (en) |
| ZA (1) | ZA985498B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| PL326490A1 (en) * | 1995-11-06 | 1998-09-28 | Lundbeck & Co As H | Treatment of traumatic brain injuries |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/en not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/en unknown
- 1998-06-25 PE PE1998000563A patent/PE116099A1/en not_active Application Discontinuation
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-26 CO CO98036576A patent/CO4940483A1/en unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/en not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/en unknown
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 EA EA200000081A patent/EA200000081A1/en unknown
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/en not_active Application Discontinuation
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/en unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 JP JP50616699A patent/JP2002507215A/en active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/en unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/en not_active Application Discontinuation
- 1998-07-01 PL PL98337184A patent/PL337184A1/en unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 CN CN98806497A patent/CN1261361A/en active Pending
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/en unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/en unknown
- 1998-07-01 SK SK1873-99A patent/SK187399A3/en unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/en not_active Application Discontinuation
-
1999
- 1999-11-30 BG BG103933A patent/BG103933A/en unknown
- 1999-11-30 IS IS5278A patent/IS5278A/en unknown
- 1999-12-30 NO NO996580A patent/NO996580L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL337184A1 (en) | 2000-08-14 |
| MA25138A1 (en) | 2001-04-02 |
| HUP0002876A2 (en) | 2001-06-28 |
| JO2031B1 (en) | 1999-05-15 |
| ZA985498B (en) | 1999-01-20 |
| BR9810331A (en) | 2000-09-05 |
| CA2293324A1 (en) | 1999-01-14 |
| EA200000081A1 (en) | 2000-08-28 |
| KR20010014297A (en) | 2001-02-26 |
| WO1999001448A1 (en) | 1999-01-14 |
| EP0994869A1 (en) | 2000-04-26 |
| CO4940483A1 (en) | 2000-07-24 |
| UY25069A1 (en) | 1998-12-21 |
| TNSN98120A1 (en) | 2005-03-15 |
| IL133093A0 (en) | 2001-03-19 |
| TR199903283T2 (en) | 2000-06-21 |
| UY25177A1 (en) | 2000-12-29 |
| AU8102098A (en) | 1999-01-25 |
| NO996580D0 (en) | 1999-12-30 |
| AR013096A1 (en) | 2000-12-13 |
| JP2002507215A (en) | 2002-03-05 |
| NO996580L (en) | 1999-12-30 |
| SK187399A3 (en) | 2000-06-12 |
| IS5278A (en) | 1999-11-30 |
| AU735751B2 (en) | 2001-07-12 |
| BG103933A (en) | 2000-07-31 |
| CN1261361A (en) | 2000-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102827067B (en) | Beta-lactamase inhibitor | |
| UA120592C2 (en) | Substituted benzofuranyl and benzoxazolyl compounds and uses thereof | |
| HUP0001547A2 (en) | Novel form of s-omeprazole | |
| NO20061050L (en) | 7- (4-Substituted-3-Cyclopropylaminomethyl-1-Pyrrolidinyl) Quinolone Carboxylic Acid Derivatives | |
| PT969819E (en) | NEW OMEPRAZOLE CRYSTALLINE FORM | |
| MA30402B1 (en) | PHENYLAMINO-BENZOXAZOLE SUBSTITUTED CARBOXYLIC ACIDS, PROCESS FOR THE PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS | |
| ATE342253T1 (en) | AZABICYCLO DERIVATIVES AS ANTAGONISTS OF THE MUSCARINIC RECEPTOR | |
| ATE144249T1 (en) | COMPOUNDS REFERRED TO IN THE INTRACEREBRAL AREA AND THEIR APPLICATION | |
| PE116099A1 (en) | 5- (2-ETIL-2-H-TETRAZOLE-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE | |
| AR015417A1 (en) | PROCEDURE TO PURIFY ALATROFLOXACINE, COMPOSITIONS, RELATED COMPOUNDS AND PROCEDURES TO TREAT INFECTIONS WITH SUCH COMPOUNDS | |
| SE0200844D0 (en) | Chemical compounds | |
| BR9913720A (en) | Purification process by crystallization or crystallization of carboxylic acids | |
| GR3003735T3 (en) | ||
| MX9300203A (en) | DISUBSTITUTED POLYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. | |
| MX9300205A (en) | DISUBSTITUTED POLYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. | |
| ES2160240T3 (en) | BENZAMIDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS. | |
| DK0632028T3 (en) | Optically active 2-nitroimidazole derivative, process for producing same and intermediate for preparation of same | |
| Zhou et al. | Synthesis of 5-substituted analogues of huperzine A | |
| Oh et al. | Synthesis of new β-lactam analogs and evaluation of their histone deacetylase (HDAC) activity | |
| NO881163L (en) | PROCEDURE FOR RECOVERING DISSOLVED SALTS AND ACIDS FROM OTHER AVAILABLE SUCH USES, BY USING IONE EXCHANGE RESIN. | |
| MX9306337A (en) | INDOLIN-2-ONAS TRICICLICAS Y TETRACICLICAS 3,3-DISUSTITUIDAS AND COMPARISONS PHARMACEUTICAL THAT CONTAIN THEM, FOR THE TREATMENT OF DISORDERS OF KNOWLEDGE. | |
| ATE432706T1 (en) | RADIOACTIVE ARSENIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUMORS | |
| ES2183843T3 (en) | TRICYCLE COMPOUNDS THAT HAVE AFFINITY FOR THE 5-HT1A RECEIVER. | |
| UA45782A (en) | METHOD OF OBTAINING SCANDIUM | |
| TH45290B (en) | Alatrofloxacin constituents given by non-oral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |